蒙牛(02319.HK)全數智化工廠投產 年產值百億人民幣
蒙牛(02319.HK)日前宣布,全球首座乳業全數智化工廠——蒙牛乳業寧夏工廠正式落成投產。作為當前全球單體最大液體奶工廠,該工廠全面投產後可實現「三個一百」,即100人創造100萬噸年產量、100億元人民幣年產值,打造出全球乳業工廠最高年度人效比,為全球乳業數智化發展注入新動能。
蒙牛總裁盧敏放在投產儀式上表示,該工廠不僅是蒙牛20多年來在自動化、數字化、智能化領域不斷積累的結果,更是融合世界領先技術,為中國乳業搶佔全球乳業智能製造的一個世界級高地。
蒙牛寧夏工廠負責人表示,工廠從開工建設到投入使用僅用了一年半的時間,再次刷新了蒙牛速度。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.